5.29 (-%)
As of Nov 22, 2024
Source:
Molecular Partners Ag is a clinical-stage biopharmaceutical company pioneering DARPin candidates to treat serious diseases, with a current focus on oncology and virology. Our DARPin platform, which is built using designed ankyrin repeat proteins, or DARPins, allows us to generate candidates with multiple mechanisms of action, or MOAs, to address complex biological problems.
| Country | Switzerland |
| Headquarters | z?rich-schlieren |
| Phone Number | 41 44 755 77 00 |
| Industry | |
| CEO | Patrick Amstutz |
| Website | www.molecularpartners.com |